CARBINOXAMINE MALEATE

Search structure
Trade Names:
Synonyms:
Status: Approved (2003)
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 02O55696WH

Structure
InChI Key GVNWHCVWDRNXAZ-BTJKTKAUSA-N
Smile CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O
InChI
InChI=1S/C16H19ClN2O.C4H4O4/c1-19(2)11-12-20-16(15-5-3-4-10-18-15)13-6-8-14(17)9-7-13;5-3(6)1-2-4(7)8/h3-10,16H,11-12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-

Physicochemical Descriptors

Property Name Value
Molecular Formula C20H23ClN2O5
Molecular Weight 406.87
AlogP 3.4
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 6.0
Polar Surface Area 25.36
Molecular species BASE
Aromatic Rings 2.0
Heavy Atoms 20.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Histamine H1 receptor antagonist FDA
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Transporter Electrochemical transporter SLC superfamily of solute carriers SLC21/SLCO family of organic anion transporting polypeptides
- - - - 85

Indications

Mesh Heading Maximum Phase Mesh ID Reference

Related Entries

MCS

Scaffolds

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Psychiatric disorders
21.05
Nervous system disorders
15.79
Gastrointestinal disorders
13.16
Immune system disorders
9.21
General disorders and administration site conditions
7.89
Cardiac disorders
6.58
Skin and subcutaneous tissue disorders
5.26
Vascular disorders
5.26
Injury, poisoning and procedural complications
3.95
Respiratory, thoracic and mediastinal disorders
3.95
Infections and infestations
2.63
Metabolism and nutrition disorders
2.63

Cross References

Resources Reference
ChEBI 31353
ChEMBL CHEMBL1200974
EPA CompTox DTXSID0047828
FDA SRS 02O55696WH
Guide to Pharmacology 7139
KEGG C06871
PubChem 5282409
SureChEMBL SCHEMBL97703
ZINC ZINC00002043
CONTENTS